期刊
NATURE COMMUNICATIONS
卷 12, 期 1, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41467-021-26735-5
关键词
-
资金
- National Institutes of Health, USA [HL143037, R35GM128641, R03TR003306]
- American Lebanese Syrian Associated Charities (ALSAC)
Ghrelin is a central orexigenic peptide hormone that activates the GHSR to stimulate food intake and growth hormone secretion. Synthetic agonists of GHSR are being evaluated for disorders related to appetite and growth hormone dysregulation. The high-resolution cryo-EM structures provide insights into the molecular basis of ghrelin and ibutamoren binding for drug design.
Ghrelin is a central orexigenic peptide hormone in human energy homeostasis that is also known as 'hunger hormone' and signals through its GPCR, GHSR. Here, the authors present the cryo-EM structures of the human GHSR-Gi signaling complex with bound ghrelin and the synthetic non-peptide agonist ibutamoren that are of interest for drug design. The hunger hormone ghrelin activates the ghrelin receptor GHSR to stimulate food intake and growth hormone secretion and regulate reward signaling. Acylation of ghrelin at Ser3 is required for its agonistic action on GHSR. Synthetic agonists of GHSR are under clinical evaluation for disorders related to appetite and growth hormone dysregulation. Here, we report high-resolution cryo-EM structures of the GHSR-G(i) signaling complex with ghrelin and the non-peptide agonist ibutamoren as an investigational new drug. Our structures together with mutagenesis data reveal the molecular basis for the binding of ghrelin and ibutamoren. Structural comparison suggests a salt bridge and an aromatic cluster near the agonist-binding pocket as important structural motifs in receptor activation. Notable structural variations of the G(i) and GHSR coupling are observed in our cryo-EM analysis. Our results provide a framework for understanding GHSR signaling and developing new GHSR agonist drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据